The Boston Globe covers the rising biorights movement and details how DNAsimple is "one of the few companies to pay for routine biological samples for research." See the full article on their website.
This week, an article in Fast Company discusses how DNAsimple's innovative model compensates donors but, more importantly, gives them control over how donations are used.
GenomeWeb, a leader in genetic reporting and journalism since 1997, published a full-length article on DNAsimple after an interview with founder Olivier Noel. You can read the full article on their website